SDIC Venture Capital

Beijing Surgerii Technology Co., Ltd. specializes in the research, development, production, and sale of minimally invasive surgical robot systems in China. Founded in 2014 and based in Beijing, the company focuses on innovative technologies, particularly the next generation of flexible continuum robotic arms. Surgerii Technology aims to transform clinical practices through its single-hole and porous laparoscopic robot systems, enhancing the standard of care in minimally invasive surgeries. With a commitment to independent research and development, the company leverages its expertise in system design and integration to advance the medical equipment industry in China.

Beijing Saifu Medical Research Institute Co., Ltd. relies on the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the National Drug Safety Evaluation and Research Center of the State of Beijing to establish strategic partnerships with them to form a combination of technology, capital and enterprise operations. The core members of the company are researchers of the Institute of Materia Medica of the Chinese Academy of Sciences and researchers of the Academy of Military Medical Sciences. They have high scientific research and academic status in the fields of drug research and development and toxicology research, as well as rich drug development, GLP management and technical experience, and build and operate the platform. Provides strong talent and technical support.

Grace Laser Technology Co., Ltd., established in 2014 and headquartered in Beijing, China, specializes in the development of laser devices for various applications, including scientific research, industrial processing, and medical aesthetics. The company is committed to advancing the national laser industry and aims to establish a renowned domestic laser brand. Grace Laser possesses a comprehensive research and development, production, and quality management system, which enables it to deliver high-quality laser products and services to its clients.

TBSTest Technology is a developer and manufacturer of automatic test equipment for integrated circuits, specializing in ultra-large-scale integrated circuit testing. Founded in 2017 and headquartered in Beijing, China, with additional offices in Xi’an and Shanghai, as well as Suwon, South Korea, the company provides a comprehensive range of products, including test boards, software solutions, and memory systems. TBSTest Technology also offers pre-sales and after-sales support for its equipment, accessories, and software systems, along with application development projects. The company serves a diverse clientele, including clients engaged in integrated circuit design and production, as well as scientific research institutions and educational establishments.

TBSTest Technology is a developer and manufacturer of automatic test equipment for integrated circuits, specializing in ultra-large-scale integrated circuit testing. Founded in 2017 and headquartered in Beijing, China, with additional offices in Xi’an and Shanghai, as well as Suwon, South Korea, the company provides a comprehensive range of products, including test boards, software solutions, and memory systems. TBSTest Technology also offers pre-sales and after-sales support for its equipment, accessories, and software systems, along with application development projects. The company serves a diverse clientele, including clients engaged in integrated circuit design and production, as well as scientific research institutions and educational establishments.

RemeGen, Ltd. is a biopharmaceutical company based in Yantai, Shandong Province, China, focused on addressing unmet medical needs for patients with life-threatening conditions. The company specializes in the research, development, manufacturing, and commercialization of innovative biologics, particularly monoclonal antibodies and antibody-drug conjugates. RemeGen's leading products include Telitacicept, aimed at treating systemic lupus erythematosus, and Disitamab Vedotin, designed for various cancers. The company’s therapeutic offerings target significant health issues, including autoimmune diseases, oncology, and ophthalmology. With operations in both China and the United States, RemeGen primarily generates its revenue from the Chinese market.

Beijing Biostar Technologies, Ltd., established in 2002, is a Chinese biopharmaceutical company based in Beijing. It specializes in the development of anti-tumor chemotherapy biopharmaceutical molecules, with a focus on creating innovative small molecule chemical drugs for cancer treatment. The company, led by a team of Chinese scientists previously based in the United States, including Dr. Tang Li and Dr. Qiu Rongguo, aims to advance its technology to an international level.

Zshield Inc. is a Beijing-based company specializing in cyberspace data security and big data business risk management. Established in 2014, it is recognized as the first high-tech firm in China to leverage big data technologies in addressing emerging information security vulnerabilities. Zshield develops advanced integrated information security solutions that utilize lightweight virtualization, deep learning, and big data analysis to provide effective monitoring of server and terminal security. Its offerings include a comprehensive information security platform and the AndunTM ZS-ISP, which supports both government and enterprise clients in navigating the complexities of modern computing environments, including cloud computing and mobile applications. As traditional security measures struggle to cope with new threats, Zshield's innovative approach aims to fortify businesses against the evolving landscape of information security challenges.

Eucure Biopharma, established in 2016 and headquartered in Beijing, China, is a biotechnology company focused on the discovery and development of innovative immuno-oncology targeted antibodies. Its pipeline comprises eight drug candidates, primarily targeting immune checkpoints, with several in the clinical trial application stage. The company offers services such as antibody production, in vivo and in vitro drug efficacy testing, and operates as a subsidiary of Beijing Biocytogen Co., Ltd. Eucure Biopharma aims to improve the survival rate of tumor patients by developing effective antibody treatments.

Beijing SkyGuard Network Security Technologies LLC, founded in 2015 and based in Beijing, China, specializes in network information security technology services. The company focuses on developing data security solutions that prioritize the protection of individuals and their data. In addition to its technology offerings, SkyGuard provides comprehensive consulting services, along with pre-sales and after-sales technical support, aimed at assisting enterprise users in enhancing their data security measures.

Eucure Biopharma, established in 2016 and headquartered in Beijing, China, is a biotechnology company focused on the discovery and development of innovative immuno-oncology targeted antibodies. Its pipeline comprises eight drug candidates, primarily targeting immune checkpoints, with several in the clinical trial application stage. The company offers services such as antibody production, in vivo and in vitro drug efficacy testing, and operates as a subsidiary of Beijing Biocytogen Co., Ltd. Eucure Biopharma aims to improve the survival rate of tumor patients by developing effective antibody treatments.

Twenty First Century Aerospace Technology Co., Ltd specializes in commercial earth observation (EO) satellite operations and geospatial information services. Based in Beijing, the company manages a constellation of small satellites, including those capable of capturing 1-meter optical imagery. It provides a comprehensive range of services encompassing satellite procurement, operational management, data acquisition, image processing, and geo-information services. The company’s offerings include high-quality imaging data, value-added images, and spatial remote sensing services, as well as software solutions for image data processing and smart satellite management. Its geo-information services cater to various applications, including land cover analysis, change detection, and 3D simulation, supporting government and commercial sectors in areas such as city management, resource monitoring, and disaster response. Founded in 2001, Twenty First Century Aerospace Technology leverages advanced technology and algorithms for large-scale data processing to serve both domestic and international clients.

Zshield Inc. is a Beijing-based company specializing in cyberspace data security and big data business risk management. Established in 2014, it is recognized as the first high-tech firm in China to leverage big data technologies in addressing emerging information security vulnerabilities. Zshield develops advanced integrated information security solutions that utilize lightweight virtualization, deep learning, and big data analysis to provide effective monitoring of server and terminal security. Its offerings include a comprehensive information security platform and the AndunTM ZS-ISP, which supports both government and enterprise clients in navigating the complexities of modern computing environments, including cloud computing and mobile applications. As traditional security measures struggle to cope with new threats, Zshield's innovative approach aims to fortify businesses against the evolving landscape of information security challenges.